PMC:7105881 / 33457-33680 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1083","span":{"begin":168,"end":172},"obj":"Gene"},{"id":"1086","span":{"begin":14,"end":22},"obj":"Species"},{"id":"1103","span":{"begin":162,"end":167},"obj":"Species"}],"attributes":[{"id":"A1083","pred":"tao:has_database_id","subj":"1083","obj":"Gene:16017"},{"id":"A1086","pred":"tao:has_database_id","subj":"1086","obj":"Tax:694009"},{"id":"A1103","pred":"tao:has_database_id","subj":"1103","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" based on the SARS-CoV RBD have been extensively explored. Studies have found that a fusion protein containing RBD and the fragment crystallizable (Fc) region of human IgG1 (RBD-Fc) elicited highly potent neutralizing antib"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T188","span":{"begin":92,"end":99},"obj":"Body_part"}],"attributes":[{"id":"A188","pred":"fma_id","subj":"T188","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":" based on the SARS-CoV RBD have been extensively explored. Studies have found that a fusion protein containing RBD and the fragment crystallizable (Fc) region of human IgG1 (RBD-Fc) elicited highly potent neutralizing antib"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T179","span":{"begin":14,"end":22},"obj":"Disease"}],"attributes":[{"id":"A179","pred":"mondo_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" based on the SARS-CoV RBD have been extensively explored. Studies have found that a fusion protein containing RBD and the fragment crystallizable (Fc) region of human IgG1 (RBD-Fc) elicited highly potent neutralizing antib"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T441","span":{"begin":83,"end":84},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T442","span":{"begin":148,"end":150},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T443","span":{"begin":162,"end":167},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T444","span":{"begin":178,"end":180},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":" based on the SARS-CoV RBD have been extensively explored. Studies have found that a fusion protein containing RBD and the fragment crystallizable (Fc) region of human IgG1 (RBD-Fc) elicited highly potent neutralizing antib"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T196","span":{"begin":92,"end":99},"obj":"Chemical"}],"attributes":[{"id":"A196","pred":"chebi_id","subj":"T196","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":" based on the SARS-CoV RBD have been extensively explored. Studies have found that a fusion protein containing RBD and the fragment crystallizable (Fc) region of human IgG1 (RBD-Fc) elicited highly potent neutralizing antib"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T560","span":{"begin":14,"end":22},"obj":"SP_10"},{"id":"T561","span":{"begin":162,"end":167},"obj":"SP_6;NCBITaxon:9606"},{"id":"T562","span":{"begin":168,"end":172},"obj":"GO:0071735"},{"id":"T58860","span":{"begin":14,"end":22},"obj":"SP_10"},{"id":"T51408","span":{"begin":162,"end":167},"obj":"SP_6;NCBITaxon:9606"},{"id":"T32600","span":{"begin":168,"end":172},"obj":"GO:0071735"}],"text":" based on the SARS-CoV RBD have been extensively explored. Studies have found that a fusion protein containing RBD and the fragment crystallizable (Fc) region of human IgG1 (RBD-Fc) elicited highly potent neutralizing antib"}